BCNatal | Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Centre for Biomedical Research on Rare Diseases (CIBER-ER), Madrid, Spain.
Trials. 2021 May 24;22(1):362. doi: 10.1186/s13063-021-05309-2.
Fetal growth restriction (FGR) affects 7-10% of all pregnancies resulting in a higher risk of perinatal morbidity and mortality, long-term disabilities, and cognitive impairment. Due to its multifactorial etiology, changes in maternal lifestyle, including suboptimal maternal diet and stress, have increasingly been associated with its prevalence. We present a protocol for the Improving Mothers for a better PrenAtal Care Trial Barcelona (IMPACT BCN), which evaluates two different maternal lifestyle strategies (improved nutrition by promoting Mediterranean diet and stress reduction program based on mindfulness techniques) on perinatal outcomes. The primary objective is to reduce the prevalence of FGR. Secondary aims are to reduce adverse perinatal outcomes and to improve neurodevelopment and cardiovascular profile in children at 2 years of age.
A randomized parallel, open-blind, single-center trial following a 1:1:1 ratio will select and randomize high-risk singleton pregnancies for FGR (N=1218), according to the criteria of the Royal College of Obstetricians and Gynaecologists (19.0-23.6 weeks' gestation), into three arms: Mediterranean diet, mindfulness-based stress reduction program, and usual care without any intervention. Compliance to the interventions will be randomly tested in 30% of participants with specific biomarkers. Maternal socio-demographic, clinical data, biological samples, and lifestyle questionnaires will be collected at enrollment and at the end of the interventions (34.0-36.6 weeks' gestation), together with a fetoplacental ultrasound and magnetic resonance. Fetoplacental biological samples and perinatal outcomes will be recorded at delivery. Postnatal follow-up is planned up to 2 years of corrected age including neurodevelopmental tests and cardiovascular assessment. Intention-to-treat and population per-protocol analysis will be performed.
This is the first randomized study evaluating the impact of maternal lifestyle interventions during pregnancy on perinatal outcomes. The maternal lifestyle interventions (Mediterranean diet and mindfulness-based stress reduction program) are supported by scientific evidence, and their compliance will be evaluated with several biomarkers.
ClinicalTrials.gov NCT03166332 . Registered on April 19, 2017.
胎儿生长受限(FGR)影响所有妊娠的 7-10%,导致围产期发病率和死亡率、长期残疾和认知障碍的风险增加。由于其多因素病因,包括母体饮食和压力不佳在内的生活方式变化与 FGR 的流行率增加有关。我们提出了一项改善母亲产前保健巴塞罗那试验(IMPACT BCN)的方案,该方案评估了两种不同的母体生活方式策略(通过促进地中海饮食和基于正念的减压计划来改善营养)对围产期结局的影响。主要目标是降低 FGR 的发生率。次要目标是降低不良围产期结局,并改善 2 岁儿童的神经发育和心血管状况。
一项随机平行、开放盲、单中心试验,按照 1:1:1 的比例,根据皇家妇产科医师学院的标准(19.0-23.6 周妊娠),选择和随机分配高危单胎妊娠 FGR(N=1218),分为三组:地中海饮食、基于正念的减压计划和无任何干预的常规护理。将以特定生物标志物随机测试 30%的参与者对干预措施的依从性。在入组时和干预结束时(34.0-36.6 周妊娠)收集母体社会人口统计学、临床数据、生物样本和生活方式问卷,并进行胎儿胎盘超声和磁共振检查。在分娩时记录胎儿胎盘生物样本和围产期结局。计划进行产后随访至 2 年纠正年龄,包括神经发育测试和心血管评估。将进行意向治疗和人群方案分析。
这是第一项评估妊娠期间母体生活方式干预对围产期结局影响的随机研究。母体生活方式干预(地中海饮食和基于正念的减压计划)有科学证据支持,并且将使用多种生物标志物评估其依从性。
ClinicalTrials.gov NCT03166332。于 2017 年 4 月 19 日注册。